Osimertinib as an emerging therapeutic modality in nonsmall cell lung cancer: Opportunities and challenges in Indian scenario

Detalles Bibliográficos
Autores principales: Thakur, Sayanta, Chakraborty, Dwaipayan Sarathi, Lahiry, Sandeep, Choudhury, Shouvik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961090/
https://www.ncbi.nlm.nih.gov/pubmed/31898629
http://dx.doi.org/10.4103/lungindia.lungindia_291_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961090/
https://www.ncbi.nlm.nih.gov/pubmed/31898629
http://dx.doi.org/10.4103/lungindia.lungindia_291_19

Ejemplares similares